You are here: Industry Insights > inflammatory disease

News List

Janssen inks inflammatory disease collaboration with Mestag Therapeutics pharmatimes
May 19, 2021
Janssen, the pharma division of Johnson & Johnson, has entered an agreement with Cambridge, UK-based Mestag Therapeutics to research and develop novel fibroblast targets for the treatment of inflammatory disease.
FairJourney Biologics, IONTAS enter antibody discovery pact with Pandion Therapeutics expresspharma
November 24, 2020
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research.
One Woman's Case Gives New Hope Against Disfiguring Sarcoidosis drugs
December 27, 2018
In very preliminary findings, an existing rheumatoid arthritis drug appeared to cure one woman of a rare but potentially life-threatening condition known as sarcoidosis.....
Entera Bio, Amgen Announce Strategic Research Collaboration americanpharmaceuticalreview
December 12, 2018
Entera Bio has entered into a research collaboration and license agreement with Amgen in inflammatory disease and other serious illnesses.....
Gilead, Verily ally to analyze immune cells from inflammatory disease patients fiercebiotech
May 02, 2018
Gilead has teamed up with Verily to analyze the effect its drugs have on the immune cells of patients with inflammatory diseases.
X-Chem, Janssen Biotech Expand Discovery Alliance contractpharma
February 17, 2017
Will apply X-Chem’s DEX platform to identify novel modulators for inflammatory disease targets
X-Chem, Janssen Biotech Expand Discovery Alliance contractpharma
February 16, 2017
Will apply X-Chem’s DEX platform to identify novel modulators for inflammatory disease targets